RE
Remedent, Inc.
REMI · OTC
$0.00 +14.29% (+$0.00)
Market Cap $16.0K
P/E Ratio -
Div. Yield -
ROE 11.11%
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/B 0.01x
P/S 0.02x
EV/FFO N/A
Growth
10 /100
Declining Book val. growth 19.24%
Rev. growth 1.43%
FCF growth N/A
Profitability
20 /100
Weak Op. margin 12.46%
Gross margin 61.17%
FCF margin 13.23%
Quality
2 /100
Poor ROA 5.00%
ROIC 5.34%
Asset turnover 0.18x
Debt
46 /100
Moderate Int. coverage -97.24x
Debt/Equity 0.01x
Current ratio 0.33x
Stability
16 /100
Unstable EPS volatility 292.45%
Beta -0.42x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about REMI
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Guy De Vreese
Employees
3
Headquarters
Gent